X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
vancomycin (1123) 1123
humans (1072) 1072
microbiology (772) 772
anti-bacterial agents - pharmacology (768) 768
antibiotics (613) 613
microbial sensitivity tests (536) 536
vancomycin - pharmacology (518) 518
pharmacology & pharmacy (451) 451
infectious diseases (424) 424
bacteria (409) 409
male (374) 374
vancomycin resistance (370) 370
animals (368) 368
female (359) 359
staphylococcus aureus - drug effects (358) 358
infections (346) 346
staphylococcus aureus (331) 331
drug resistance in microorganisms (308) 308
anti-bacterial agents - therapeutic use (306) 306
drug resistance (289) 289
biochemistry & molecular biology (278) 278
middle aged (269) 269
research (255) 255
analysis (240) 240
aged (227) 227
biochemical phenomena, metabolism, and nutrition (223) 223
bacterial proteins - genetics (221) 221
staphylococcal infections - microbiology (221) 221
research article (219) 219
resistance (218) 218
health aspects (217) 217
staphylococcal infections - drug therapy (217) 217
staphylococcus-aureus (215) 215
escherichia-coli (212) 212
adult (211) 211
vancomycin - therapeutic use (197) 197
infection (186) 186
drug resistance, bacterial (183) 183
antibacterial agents (182) 182
antimicrobial agents (180) 180
staphylococcus infections (179) 179
antibiotic resistance (175) 175
multidisciplinary sciences (172) 172
methicillin-resistant staphylococcus aureus - drug effects (170) 170
risk factors (170) 170
enterococcus - drug effects (169) 169
medicine (169) 169
bacteremia (166) 166
staphylococcus aureus - physiology (162) 162
susceptibility (155) 155
anti-bacterial agents - administration & dosage (151) 151
anti-bacterial agents - chemistry (151) 151
bacterial proteins - metabolism (151) 151
staphylococcus aureus infections (151) 151
mortality (150) 150
pathogens (142) 142
methicillin (140) 140
biofilms - drug effects (138) 138
biofilms (137) 137
immunology (136) 136
mice (135) 135
epidemiology (133) 133
molecular sequence data (132) 132
vancomycin - administration & dosage (131) 131
gram-positive bacterial infections - microbiology (130) 130
therapy (130) 130
antimicrobial resistance (129) 129
hospitals (128) 128
retrospective studies (126) 126
virulence (123) 123
in-vitro (122) 122
physiological aspects (122) 122
strains (122) 122
treatment outcome (122) 122
methicillin resistance (121) 121
nosocomial infections (121) 121
science (121) 121
genes (119) 119
identification (116) 116
linezolid (115) 115
staphylococcus aureus - genetics (115) 115
biofilms - growth & development (113) 113
enterococcus faecium - drug effects (113) 113
gram-positive bacteria (113) 113
antibiotic-resistance (112) 112
chemistry, medicinal (112) 112
vancomycin-resistant enterococci (112) 112
vancomycin resistance - physiology (111) 111
daptomycin (108) 108
drug resistance, microbial (107) 107
enterococcus (107) 107
mrsa (104) 104
resistant staphylococcus-aureus (104) 104
care and treatment (102) 102
methicillin-resistant staphylococcus aureus (102) 102
aged, 80 and over (101) 101
glycopeptide resistance (100) 100
proteins (100) 100
pharmacology (99) 99
chemistry, organic (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2051) 2051
Japanese (24) 24
Spanish (10) 10
French (5) 5
Turkish (4) 4
German (3) 3
Chinese (2) 2
Polish (2) 2
Russian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases, ISSN 1537-6591, 2006, Volume 42, Issue Supplement_1, pp. S25 - S34
Journal Article
Journal of Endodontics, ISSN 0099-2399, 2014, Volume 40, Issue 2, pp. 223 - 230
.... However, endodontic clinical bacterial isolates have not been sufficiently characterized with regard to their capacity for antibiotic resistance and biofilm formation... 
Endocrinology & Metabolism | Dentistry | endodontic infection | apical periodontitis | Antibiotic resistance | biofilm | ANTIMICROBIAL SUSCEPTIBILITY | ENTEROCOCCUS-FAECALIS | PERIRADICULAR LESIONS | MICROORGANISMS | IN-VITRO | PERIAPICAL LESIONS | BROTH MICRODILUTION | DENTISTRY, ORAL SURGERY & MEDICINE | GENE-TRANSFER | ENTERIC BACTERIA | Gram-Positive Bacteria - physiology | Enterococcus faecalis - drug effects | Actinomyces viscosus - drug effects | Gram-Positive Bacteria - drug effects | Propionibacterium - drug effects | Clindamycin | Humans | Prevotella - physiology | Streptococcus mutans - physiology | Actinomyces viscosus - physiology | Gentamicins - pharmacology | Penicillin Resistance | Lactobacillus fermentum - drug effects | Lactobacillus fermentum - physiology | Gram-Negative Bacteria - physiology | Actinomyces - physiology | Propionibacterium - physiology | Actinomyces - drug effects | Fosfomycin - pharmacology | Dental Pulp Diseases - microbiology | Ciprofloxacin - pharmacology | Vancomycin Resistance | Streptococcus mutans - drug effects | Tetracycline Resistance | Penicillin G - pharmacology | Tooth, Nonvital - microbiology | Prevotella - drug effects | Gram-Negative Bacteria - drug effects | Biofilms | Amoxicillin - pharmacology | Fluoroquinolones - pharmacology | Drug Resistance, Bacterial - physiology | Doxycycline - pharmacology | Anti-Bacterial Agents - pharmacology | Rifampin - pharmacology | Enterococcus faecalis - physiology | Drug resistance in microorganisms | Bacteria | Root canal therapy | Health aspects
Journal Article
Cell host & microbe, ISSN 1931-3128, 2017, Volume 21, Issue 5, pp. 592 - 602.e4
Antibiotic-mediated microbiota destruction and the consequent loss of colonization resistance can result in intestinal domination with vancomycin-resistant Enterococcus (VRE... 
Enterococcus | microbiota | Enterococcus faecium | intestinal domination | antibiotic resistance | Blautia product | commensal bacteria | colonization resistance | vancomycin resistance | microbiome | INTESTINAL MICROBIOTA | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | MECHANISMS | GUT MICROBIOTA | CLOSTRIDIUM-DIFFICILE | TRANSPLANTATION | THERAPY | VIROLOGY | DOMINATION | MICE | INFECTION | PARASITOLOGY | Vancomycin-Resistant Enterococci - pathogenicity | Vancomycin-Resistant Enterococci - growth & development | Symbiosis - physiology | Drug Resistance, Bacterial | Colony Count, Microbial | DNA, Bacterial | Feces - microbiology | Vancomycin - pharmacology | Gram-Positive Bacterial Infections - microbiology | Female | Ampicillin - pharmacology | Vancomycin-Resistant Enterococci - genetics | Microbiota - physiology | Mice, Inbred C57BL | Clostridium - physiology | Bacterial Physiological Phenomena | Bacteria - genetics | Bacteria - isolation & purification | Animals | Intestines - microbiology | Enterococcus faecium - pathogenicity | RNA, Ribosomal, 16S - genetics | Anti-Bacterial Agents - pharmacology | Mice | Enterococcus faecium - growth & development | Gram-Positive Bacterial Infections - prevention & control | Drug resistance in microorganisms | Bacteria | Vancomycin | Microbiota (Symbiotic organisms) | College graduates
Journal Article
Journal Article
Nature reviews. Microbiology, ISSN 1740-1534, 2012, Volume 10, Issue 4, pp. 266 - 278
Journal Article
Infection and immunity, ISSN 1098-5522, 2019, Volume 87, Issue 6
is a human intestinal pathobiont with intrinsic and acquired resistance to many antibiotics, including vancomycin... 
Enterococcus | RESCUES MICE | INFECTIOUS DISEASES | FAECIUM | intestinal colonization | bacteriophages | IMMUNOLOGY | DAPTOMYCIN | exopolysaccharide | CAPSULAR POLYSACCHARIDE | INVASION | THERAPY | GENE | antibiotic resistance | EPA | FAECALIS | CLUSTER | dysbiosis
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2006, Volume 34, Issue 5, pp. S11 - S19
Gram-positive bacteria are common causes of bloodstream and other infections in hospitalized patients in the United States, and the percentage of nosocomial... 
Enterococcus faecalis | Penicillanic Acid - pharmacology | Gram-Positive Bacteria - physiology | Humans | Gastrointestinal Tract - microbiology | Cross Infection - drug therapy | Piperacillin - pharmacology | Vancomycin Resistance - physiology | Animals | Community-Acquired Infections - drug therapy | Cross Infection - microbiology | beta-Lactamase Inhibitors | Drug Resistance, Bacterial - genetics | Gram-Positive Bacterial Infections - drug therapy | Methicillin Resistance | Cephalosporins - pharmacology | Community-Acquired Infections - microbiology | Drug Combinations | Penicillanic Acid - analogs & derivatives | gram-positive bacteria | VALENTINE LEUKOCIDIN GENES | vancomycin-resistant enterococci | methicillin-resistant Staphylococcus aureus | VANCOMYCIN RESISTANCE | METHICILLIN-RESISTANT | EPIDEMIOLOGIC OBSERVATIONS | PNEUMOCOCCAL CONJUGATE VACCINE | MEDICINE, GENERAL & INTERNAL | UNITED-STATES HOSPITALS | MOUSE GASTROINTESTINAL-TRACT | antimicrobial resistance | STAPHYLOCOCCUS-AUREUS INFECTIONS | ENTEROCOCCUS-FAECIUM | nosocomial infections | BLOOD-STREAM INFECTIONS | Prevention | Intensive care units | Staphylococcal infections | Causes of | Management | Pneumococcal vaccine | Health aspects | Staphylococcus aureus | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Caprolactam | Medical care | Cross infection | Nosocomial infections | Antibacterial agents | Quality management
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 07/2017, Volume 23, Issue 25, pp. 4654 - 4660
AIM To systematically review literature upon aetiology of nosocomial spontaneous bacterial peritonitis (N-SBP) given the rising importance of... 
Cirrhosis | Multidrug resistant bacteria | Nosocomial spontaneous bacterial peritonitis | Hospital-acquired infections | Critically ill patient | hospital-acquired infections Nosocomial | critically ill patient | multidrug resistant bacteria | INFECTIONS | RISK-FACTORS | MANAGEMENT | ACQUISITION | FAILURE | LIVER-CIRRHOSIS | CHALLENGE | IMPACT | CIRRHOTIC-PATIENTS | spontaneous bacterial peritonitis | GASTROENTEROLOGY & HEPATOLOGY | cirrhosis | Pseudomonas aeruginosa - isolation & purification | Hospitals - standards | Humans | Methicillin - therapeutic use | Cross Infection - mortality | Enterobacteriaceae - isolation & purification | Pseudomonas aeruginosa - physiology | Methicillin - pharmacology | Anti-Bacterial Agents - therapeutic use | Vancomycin-Resistant Enterococci - physiology | Peritonitis - microbiology | Carbapenems - pharmacology | Hospitals - statistics & numerical data | Drug Resistance, Multiple, Bacterial | Enterobacteriaceae - physiology | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Daptomycin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - physiology | Bacterial Infections - drug therapy | Liver Cirrhosis - complications | Treatment Outcome | Peritonitis - mortality | Cross Infection - drug therapy | Drug Therapy, Combination - methods | Vancomycin-Resistant Enterococci - isolation & purification | Carbapenems - therapeutic use | Cross Infection - microbiology | Liver Cirrhosis - microbiology | Anti-Bacterial Agents - pharmacology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Peritonitis - drug therapy | Bacterial Infections - mortality | Drug Therapy, Combination - standards | Practice Guidelines as Topic | Systematic Reviews
Journal Article
Molecular Microbiology, ISSN 0950-382X, 05/2004, Volume 52, Issue 4, pp. 1107 - 1121
Journal Article